tiprankstipranks
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
ONCO
Oncopeptides AB
RESEARCH TOOLSreports
Want to see SE:ONCO full AI Analyst Report?

Oncopeptides AB (ONCO) Financial Statements

9 Followers

Oncopeptides AB Financial Overview

Oncopeptides AB's market cap is currently kr757.09M. The company's EPS TTM is kr-1.27; its P/E ratio is -2.96; Oncopeptides AB is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 71.12Mkr 31.65Mkr 35.22Mkr 8.36Mkr 118.30M
Gross Profitkr 68.67Mkr 28.98Mkr 36.30Mkr 8.35Mkr 65.17M
Operating Incomekr -228.82Mkr -283.50Mkr -253.45Mkr -349.35Mkr -1.42B
EBITDAkr -228.82Mkr -261.81Mkr -231.62Mkr -319.62Mkr -1.40B
Net Incomekr -249.59Mkr -284.61Mkr -249.11Mkr -337.95Mkr -1.43B
Balance Sheet
Cash & Short-Term Investmentskr 82.25Mkr 178.54Mkr 173.44Mkr 344.51Mkr 364.30M
Total Assetskr 134.84Mkr 244.19Mkr 238.38Mkr 385.32Mkr 439.38M
Total Debtkr 126.68Mkr 141.72Mkr 126.16Mkr 9.54Mkr 14.19M
Net Debtkr 44.43Mkr -36.82Mkr -47.25Mkr -334.97Mkr -347.99M
Total Liabilitieskr 193.73Mkr 189.91Mkr 181.60Mkr 91.03Mkr 228.51M
Stockholders' Equitykr -58.89Mkr 54.28Mkr 56.78Mkr 294.29Mkr 210.87M
Cash Flow
Free Cash Flowkr -222.88Mkr -260.57Mkr -279.61Mkr -423.02Mkr -1.52B
Operating Cash Flowkr -222.88Mkr -260.57Mkr -279.49Mkr -420.51Mkr -1.52B
Investing Cash Flowkr 0.00kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00K
Financing Cash Flowkr 128.55Mkr 263.81Mkr 106.89Mkr 392.40Mkr 1.03B
Currency in SEK

Oncopeptides AB Earnings and Revenue History

Income Statement >

Oncopeptides AB Debt to Assets

Balance Sheet >

Oncopeptides AB Cash Flow

Cash Flow >

Oncopeptides AB Forecast EPS vs Actual EPS

Earnings >